Literature DB >> 14961031

Prophylactic intrathecal chemotherapy in acute promyelocytic leukemia (APL).

F Ravandi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14961031     DOI： 10.1038/sj.leu.2403306

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

1.  Central nervous system relapse in a patient with acute promyelocytic leukaemia: does the risk stratification matter?

Authors:  Deniz Goren Sahin; Eren Gunduz; Olga Meltem Akay; Zafer Gulbas
Journal:  BMJ Case Rep       Date:  2013-06-06

2.  Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin.

Authors:  Farhad Ravandi; Eli Estey; Dan Jones; Stefan Faderl; Susan O'Brien; Jackie Fiorentino; Sherry Pierce; Deborah Blamble; Zeev Estrov; William Wierda; Alessandra Ferrajoli; Srdan Verstovsek; Guillermo Garcia-Manero; Jorge Cortes; Hagop Kantarjian
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

3.  Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience.

Authors:  Arturo Vega-Ruiz; Stefan Faderl; Zeev Estrov; Sherry Pierce; Jorge Cortes; Hagop Kantarjian; Farhad Ravandi
Journal:  Int J Hematol       Date:  2009-04-02       Impact factor: 2.490
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.